Treace Medical Concepts, Inc. Class Action: The Gross Law Firm Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 - TMCI

1. TMCI faces a class action over misleading statements during 2023-2024. 2. Allegations cite unmet competition impacting Lapiplasty demand and revenue. 3. Company must expedite alternative product development due to declining sales. 4. Shareholders can participate without being lead plaintiffs for potential recovery. 5. The deadline for investor registration is June 10, 2025.

Legal

75

4m saved

Insight

Article

FAQ

Why Bearish?

The ongoing class action and negative allegations can erode investor confidence, leading to stock price decline; historical precedent in similar lawsuits shows significant short-term price impacts.

How important is it?

The legal issues raised directly threaten TMCI's market perception and potential recovery paths for affected shareholders, as indicated by the serious nature of the allegations.

Why Short Term?

The class action notice and allegations are likely to create immediate pressure on TMCI's stock price, especially leading up to the registration deadline.

Related Companies

MRCY SYK ZBH

NEW YORK, April 24, 2025 /PRNewswire/

The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).

Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=144673&from=4

CLASS PERIOD: May 8, 2023 to May 7, 2024

ALLEGATIONS:

The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that:

(1) competition impacted the demand for and utilization of its primary product, the 3D bunion correction system, the "Lapiplasty";
(2) as a result, Treace Medical's revenue declined and the Company needed to accelerate its plans to offer a product that was an alternative to osteotomy (a surgical procedure that involves cutting and realigning a bone to improve its position or function); and
(3) defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

DEADLINE:

June 10, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=144673&from=4

NEXT STEPS FOR SHAREHOLDERS:

Once you register as a shareholder who purchased shares of TMCI during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is June 10, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM?

The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

SOURCE The Gross Law Firm